Skip to main content
BALAXI PHARMACEUTICALS LIMITED logo

BALAXI PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · BALAXI ISIN · INE618N01022 LEI · 894500VRENAYIIWHHQ13 National Stock Exchange of India Wholesale and retail trade
Filings indexed 607 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BALAXI

About BALAXI PHARMACEUTICALS LIMITED

https://www.balaxipharma.in/

Balaxi Pharmaceuticals Limited is a specialty pharmaceutical company that operates an asset-light business model focused on sourcing, branding, and distributing generic formulations in frontier markets. The company primarily serves emerging economies across Africa and Latin America, including Angola, Guatemala, and the Dominican Republic. Its product portfolio encompasses a wide range of therapeutic segments such as anti-infectives, analgesics, and antimalarials. Balaxi manages an integrated supply chain, leveraging its regulatory expertise to register and market high-quality pharmaceutical products. By maintaining a robust distribution network and localized presence, the company ensures the availability of essential medicines in underserved regions while optimizing operational efficiency through its specialized procurement and logistics framework.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a compliance report submitted to the stock exchange under SEBI circular requirements, providing details on re‐lodgement of physical share transfer requests. It does not present financial results, management discussion, or constitute a financial report itself, but rather is a regulatory filing/notification. Thus it is best classified as a Regulatory Filing (RNS).
2026-05-12 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-18 English
Updates
Regulatory Filings
2026-04-14 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-13 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2026. It is issued by the Registrar and Share Transfer Agent confirming compliance related to dematerialization of securities. The document is a regulatory compliance certificate submitted to the stock exchange and does not contain financial statements or detailed financial data. It is primarily an attestation/certification letter related to regulatory requirements. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and not a financial report or announcement of a report.
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.